Archives: Contractor Email

Dear Contractor

Please see below the Zoom login details for the CPNI Annual General Meeting taking place at 8.00pm next Thursday, 25th February 2021.

Please note that admission to this meeting will be restricted to pharmaceutical contractors and superintendents of bodies corporate (Limited Companies) only.

Topic: CPNI Annual General Meeting – Thursday 25th February 2021
Time: Feb 25, 2021 08:00 PM London

Join Zoom Meeting
https://us02web.zoom.us/j/81382246589?pwd=MVlBMkUrSGIvV0xzVi92MEJvNHArdz09

Meeting ID: 813 8224 6589
Passcode: 856022
One tap mobile
+442030512874,,81382246589#,,,,*856022# United Kingdom
+442034815237,,81382246589#,,,,*856022# United Kingdom

Meeting ID: 813 8224 6589
Passcode: 856022
Find your local number: https://us02web.zoom.us/u/kjfklHThg

Preliminary Notice ( Sent Wednesday 3 February 2021 )

Dear Colleague

PRELIMINARY NOTICE is hereby given that the First Annual General Meeting of the Members of the Company will be held at 8.00pm at the registered office, 5 Annadale Avenue, Belfast BT7 3JH, on Thursday 25 February 2021 for the purpose of considering the following business:

  1. Notice of meeting.
  2. Apologies for absence.
  3. Directors’ Report on Company Activity in 2020.
  4. Chairman’s Report
  5. Report on the Summary Income Statement and Balance Sheet for the year ended 31 October 2019.
  6. Appointment of Auditors
  7. Appointment of Solicitors
  8. Closing remarks by the Chairman

AGM papers will be sent out by post on or before 15 February 2021.

Due to the current COVID restrictions the AGM will take place by ZOOM, with login details being provided in advance of the AGM.

By order of the Board

SENT ON BEHALF OF GERARD GREENE
Chief Executive
3 February 2021

Dear Colleague

A copy of the CPNI response to the above consultation, approved by CPNI Directors at the February Board meeting, is available here within the Members section of the CPNI website. 

I would encourage Contractors to also submit a response to the Consultation either by stating that you support the response made by CPNI, or by using points made in the CPNI response if writing your own response.

Responses should be submitted to Tom.Coyle@hscni.net on or before the closing date of Friday 19 February 2021.

A copy of the HSCB Consultation is available here.

Please do not hesitate to contact the CPNI office on 028 9069 0444 if you have any further questions.

Yours sincerely

SENT ON BEHALF OF GERARD GREENE
Chief Executive

Dear Colleague

Further to correspondence here, from Kathryn Turner, Pharmacy Lead, Health and Social Care Board on Tuesday 9 February 2021.

DEADLINE REMINDER

  • Contractors are asked to review the correspondence.
  • If interested in provision of a Community Pharmacy COVID-19 Vaccination Service initially using the AstraZeneca COVID-19 Vaccine, please complete the expression of interest form attached here (Annex A) and return to local offices by Friday 19 February 2021.
  • If you have any queries please in relation to this service contact either: Chris Blayney (chris.blayney@hscni.net) or Greg Miller (greg.miller@hscni.net).

Kind regards

SENT ON BEHALF OF GERARD GREENE
Chief Executive

Dear Colleague

The following concessionary prices have been granted for February 2021:

DrugPack SizeConcessionary Price
Chlorpromazine 50mg tablets28£21.29
Ciprofloxacin 500mg tablets10£3.69
Duloxetine 30mg gastro-resistant capsules28£2.77
Duloxetine 60mg gastro-resistant capsules28£3.50
Enalapril 10mg tablets28£5.99
Enalapril 20mg tablets28£10.10
Esomeprazole 20mg gastro-resistant capsules28£3.99
Esomeprazole 20mg gastro-resistant tablets28£5.30
Esomeprazole 40mg gastro-resistant capsules28£6.20
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets28£15.93
Lamotrigine 100mg tablets56£5.20
Lamotrigine 25mg tablets56£2.30
Lamotrigine 50mg tablets56£4.50
Moxonidine 200microgram tablets28£8.61
Moxonidine 300microgram tablets28£6.93
Moxonidine 400microgram tablets28£7.50
Olmesartan medoxomil 10mg tablets28£10.31
Olmesartan medoxomil 20mg tablets28£12.29
Pramipexole 88microgram tablets30£4.16
Pregabalin 100mg capsules84£6.99
Pregabalin 150mg capsules56£3.12
Pregabalin 200mg capsules84£7.99
Pregabalin 25mg capsules56£2.15
Pregabalin 300mg capsules56£6.09
Pregabalin 50mg capsules84£5.70
Pregabalin 75mg capsules56£5.32
Ropinirole 1mg tablets84£26.99
Sulfasalazine 500mg tablets112£8.38
Tamoxifen 20mg tablets30£9.67
Topiramate 25mg capsules60£22.18
Zonisamide 100mg capsules56£55.41

This is the first update of concessionary prices for February 2021.

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.

Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter. Concessionary prices are also published on the CPNI website.

Kinds regards – stay safe – Gareth

SENT ON BEHALF OF DR. GARETH C. GILVARY
Governance & Support Pharmacist

Dear Colleague
It is nearly a year since the stark reality of COVID-19 became part of our everyday lives, changing the face of healthcare overnight. During this time, the dedication and commitment displayed by community pharmacy teams in supporting their local communities has been clearly visible and recognised in both public and political arenas.

As one of the key primary healthcare providers on the ground, community pharmacy teams worked tirelessly to maintain the safe supply of medicines, whilst helping to ensure patients and communities were looked after.  As we approach this one-year mark, I would like to thank you and your pharmacy teams for the outstanding contribution you have made throughout the challenges of the past twelve months.
 
I would also like to make a call to the network to share with CPNI examples of their experiences of the pandemic. By sharing your story, we can show through the eyes of community pharmacy teams, the important role played by each staff member. 
 
Examples of this could be a delivery driver bringing medicines to those who are socially isolated, in many cases the only person some patients see, or an important intervention made by a pharmacist to diagnose, refer or prevent significant patient harm. Community pharmacy often takes these occurrences in its stride, part of everyday life, but it is important to capture these examples as they demonstrate the accessibility and importance of community pharmacy and the many layers of support provided to local communities, particularly during a pandemic.
 
I have attached a media example which provides an insightful look into some of work carried out by a local contractor, Anita Gribben who kindly shared some of her team’s experience during COVID-19.
 
If you would like to share your story, or the story of one of your team members, or if you want to find out more information, please contact Jude Austin, CPNI Communications Manager – judea@communitypharmacyni.co.uk.

Kind regards

SENT ON BEHALF OF GERARD GREENE
Chief Executive

For the immediate attention of the manager in charge of payroll/human resources

Dear Contractor

Joe Brogan, Head of Pharmacy and Medicines Management, HSCB, has written to all community pharmacies confirming that the Health Minister has asked for the establishment of a bonus scheme, up to the value of £500 per individual, for those who have completed a minimum of one full month’s employment in the delivery of HSC services during the period 17 March 2020 – 31 January 2021.

The community pharmacy workforce is included in this scheme in further recognition of their critical role during the COVID pandemic, and this is most welcome.

Action

Contractors are asked to urgently:

  • Note the content of the letter
  • Ensure that this is brought to the immediate attention of the manager in charge of payroll/human resources; and
  • Ensure that the survey is completed and returned by 5pm, Friday 19 February 2021.

Any queries should be directed to your local HSC Office.

Regards

SENT ON BEHALF OF GERARD GREENE
Chief Executive